Clinical Trials in Kaili, China
2 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Phase 2Phase 3
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Corxel Pharmaceuticals740 enrolled83 locationsNCT06990867
Recruiting
Phase 3
Early Antiplatelet Administration After Intravenous Thrombolysis for Acute Ischemic Stroke (TREND-IVT)
Acute Ischemic StrokeCerebral Infarction
Capital Medical University1,184 enrolled71 locationsNCT06548971
Recruiting
CHina Adrenal Venous saMPling InvestigatiON
AdrenalectomyHyperaldosteronismAdrenal Venous Sampling
Chinese Academy of Medical Sciences, Fuwai Hospital5,000 enrolled76 locationsNCT07252284
Recruiting
Not Applicable
Treatment of Vasospasm of Aneurysmal Subarachnoid Hemorrhage With Intrathecal Nicardipine - FAST-IT Trial
Aneurysmal Subarachnoid HemorrhageVasospasm
The Affiliated Hospital Of Guizhou Medical University396 enrolled28 locationsNCT06329635
Recruiting
Phase 4
REmimazolam vs Propofol Total Intravenous Anesthesia on Outcomes After Major Noncardiac SurgEry
AnesthesiaSurgery--Complications
Nanfang Hospital, Southern Medical University7,188 enrolled44 locationsNCT05728775
Recruiting
Phase 3
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
multidrug-resistant tuberculosisRifampicin Resistant TuberculosisPre-XDR-TB
Huashan Hospital1,050 enrolled5 locationsNCT05081401
Recruiting
Phase 2Phase 3
Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
Tuberculosis, Pulmonary
Huashan Hospital2,442 enrolled6 locationsNCT05401071